Renhe Pharmacy Co.,Ltd (SHE:000650)
China
· Delayed Price · Currency is CNY 5.38
0.00 (0.00%)
Apr 30, 2025, 3:04 PM CST
Renhe Pharmacy Co.,Ltd Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 3,823 | 4,075 | 4,927 | 5,075 | 4,841 | 4,211 | Upgrade
|
| Other Revenue | - | - | 105.17 | 78.56 | 94.45 | 67.03 | Upgrade
|
| Revenue | 3,823 | 4,075 | 5,032 | 5,153 | 4,936 | 4,278 | Upgrade
|
| Revenue Growth (YoY) | -22.20% | -19.02% | -2.35% | 4.41% | 15.38% | -6.62% | Upgrade
|
| Cost of Revenue | 2,367 | 2,529 | 3,187 | 3,308 | 3,071 | 2,609 | Upgrade
|
| Gross Profit | 1,455 | 1,546 | 1,845 | 1,845 | 1,865 | 1,669 | Upgrade
|
| Selling, General & Admin | 670.87 | 753.33 | 804.72 | 864.65 | 850.05 | 799.93 | Upgrade
|
| Research & Development | 45.51 | 43.85 | 46.36 | 50.54 | 52.14 | 39.79 | Upgrade
|
| Other Operating Expenses | -58.31 | -67.67 | 46 | 44.46 | 37.76 | 35.77 | Upgrade
|
| Operating Expenses | 658.07 | 729.51 | 901 | 966.32 | 942.38 | 877.06 | Upgrade
|
| Operating Income | 797.4 | 816.5 | 943.83 | 878.95 | 922.49 | 791.72 | Upgrade
|
| Interest Expense | - | - | -0.35 | -0.43 | -0.98 | -1.42 | Upgrade
|
| Interest & Investment Income | 80.51 | 72.7 | 87.92 | 70.49 | 88.18 | 82.09 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -0 | -0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -24.48 | -18.67 | -3.39 | -0.69 | -2.01 | -13.9 | Upgrade
|
| EBT Excluding Unusual Items | 853.43 | 870.54 | 1,028 | 948.33 | 1,008 | 858.49 | Upgrade
|
| Impairment of Goodwill | - | - | -31.33 | -27.89 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 16.87 | 16.03 | 16.83 | 22.11 | -0.03 | -0.12 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.57 | 1.37 | -0.27 | 0.34 | 16.84 | 0.02 | Upgrade
|
| Asset Writedown | -113.27 | -113.32 | -176.3 | -4.53 | -1.44 | - | Upgrade
|
| Other Unusual Items | - | - | 61.91 | 15.18 | 11.37 | 10.39 | Upgrade
|
| Pretax Income | 758.6 | 774.62 | 898.86 | 953.54 | 1,034 | 868.79 | Upgrade
|
| Income Tax Expense | 205.07 | 208.03 | 269.45 | 242 | 234.54 | 194.49 | Upgrade
|
| Earnings From Continuing Operations | 553.52 | 566.59 | 629.41 | 711.54 | 799.87 | 674.29 | Upgrade
|
| Minority Interest in Earnings | -84.6 | -84.67 | -62.15 | -137.11 | -134.85 | -94.11 | Upgrade
|
| Net Income | 468.92 | 481.91 | 567.26 | 574.43 | 665.02 | 580.18 | Upgrade
|
| Net Income to Common | 468.92 | 481.91 | 567.26 | 574.43 | 665.02 | 580.18 | Upgrade
|
| Net Income Growth | -16.60% | -15.04% | -1.25% | -13.62% | 14.62% | 7.88% | Upgrade
|
| Shares Outstanding (Basic) | 1,377 | 1,377 | 1,384 | 1,401 | 1,385 | 1,261 | Upgrade
|
| Shares Outstanding (Diluted) | 1,395 | 1,395 | 1,384 | 1,401 | 1,385 | 1,261 | Upgrade
|
| Shares Change (YoY) | -0.36% | 0.84% | -1.25% | 1.13% | 9.85% | 0.84% | Upgrade
|
| EPS (Basic) | 0.34 | 0.35 | 0.41 | 0.41 | 0.48 | 0.46 | Upgrade
|
| EPS (Diluted) | 0.34 | 0.35 | 0.41 | 0.41 | 0.48 | 0.46 | Upgrade
|
| EPS Growth | -16.30% | -15.76% | - | -14.58% | 4.35% | 6.98% | Upgrade
|
| Free Cash Flow | 319.89 | 271.54 | 312.92 | 1,049 | 277.93 | 665.69 | Upgrade
|
| Free Cash Flow Per Share | 0.23 | 0.20 | 0.23 | 0.75 | 0.20 | 0.53 | Upgrade
|
| Dividend Per Share | - | - | 0.200 | 0.200 | 0.100 | 0.200 | Upgrade
|
| Dividend Growth | - | - | - | 100.00% | -50.00% | 100.00% | Upgrade
|
| Gross Margin | 38.07% | 37.94% | 36.66% | 35.81% | 37.78% | 39.01% | Upgrade
|
| Operating Margin | 20.86% | 20.04% | 18.76% | 17.06% | 18.69% | 18.51% | Upgrade
|
| Profit Margin | 12.27% | 11.83% | 11.27% | 11.15% | 13.47% | 13.56% | Upgrade
|
| Free Cash Flow Margin | 8.37% | 6.66% | 6.22% | 20.35% | 5.63% | 15.56% | Upgrade
|
| EBITDA | 909.47 | 933.11 | 1,079 | 990.73 | 1,006 | 873.92 | Upgrade
|
| EBITDA Margin | 23.79% | 22.90% | 21.43% | 19.23% | 20.37% | 20.43% | Upgrade
|
| D&A For EBITDA | 112.07 | 116.61 | 134.74 | 111.78 | 83.15 | 82.2 | Upgrade
|
| EBIT | 797.4 | 816.5 | 943.83 | 878.95 | 922.49 | 791.72 | Upgrade
|
| EBIT Margin | 20.86% | 20.04% | 18.76% | 17.06% | 18.69% | 18.51% | Upgrade
|
| Effective Tax Rate | 27.03% | 26.86% | 29.98% | 25.38% | 22.67% | 22.39% | Upgrade
|
| Revenue as Reported | - | - | 5,032 | 5,153 | 4,936 | 4,278 | Upgrade
|
| Advertising Expenses | - | - | 206.17 | 217.09 | 215 | 168.39 | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.